Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Dec-23
- 19-Sep-24
- 17-Oct-24
- 14-Nov-24
- 21-Nov-24
Select bar for recommendation details.
Recommendations | 21-Nov-24 | |
---|---|---|
Buy | 1 | |
Outperform | 1 | |
Hold | 1 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 3 analysts offering 12 month price targets for Immunitybio Inc have a median target of 8.00, with a high estimate of 30.00 and a low estimate of 4.75. The median estimate represents a 58.89% increase from the last price of 5.04.
High | 495.8% | 30.00 |
Med | 58.9% | 8.00 |
Low | -5.7% | 4.75 |
Earnings history & estimates in USD
The next earnings announcement is expected on Mar 17, 2025.
Average growth rate | -0.34% |
Average growth rate | -13.64% |
More ▼
Revenue history & estimates in USD
Average growth rate | +749.74% |
Average growth rate | +246.11% |
More ▼